Ameritas Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Ameritas Advisory Services's IHE Position: Q3 2026 in Review
Ameritas Advisory Services increased its iShares US Pharmaceuticals ETF (IHE) stake by 13% in Q3 2026, buying an estimated $34.3K and bringing the position to 2,905 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #957.
Ameritas Advisory Services first reported a position in IHE in Q1 2023 and has held it in 5 quarters since. 249 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- Ameritas Advisory Services held 2,905 shares of iShares US Pharmaceuticals ETF worth $292K as of Q3 2026.
- Ameritas Advisory Services bought 334 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $34.3K.
- iShares US Pharmaceuticals ETF made up 0.01% of Ameritas Advisory Services's portfolio in Q3 2026, its #957 holding.
- Ameritas Advisory Services first reported a position in iShares US Pharmaceuticals ETF in Q1 2023 and has held it in 5 quarters since.
- 249 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on Ameritas Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.